Amedisys (NASDAQ: AMED)
Amedisys Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Amedisys Company Info
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.
News & Analysis
Why Shares of Amedisys Are Jumping Monday
The home healthcare company received a buyout offer from a segment of UnitedHealth Group.
Why Amedisys Stock Is Crashing Today
The company provided disappointing full-year guidance.
Why Amedisys' Q4 Results Could Be a Speed Bump for the High-Flying Stock
A revenue miss and a narrow earnings beat weren't what investors hoped for in Q4.
3 Home Care Stocks That Outperformed in 2019
Here's why they might do it again in 2020 and beyond.
How Amedisys Blew Past Q3 Earnings Estimates
Hint: Adjusted earnings numbers can involve plenty of adjustments.
Amedisys Q2 Earnings: By the Numbers and Behind the Numbers
Here's what you need to know about the home health and hospice provider's Q2 earnings results.
Why Amedisys Shares Slumped 24.6% In July
Officials in Washington have laid out a plan to cut what Medicare pays for home healthcare, and that's hammering the stocks of companies that provide those services.
Why Amedisys Is Crashing 14.3% Today
Government reimbursement rates may slip 0.4% in 2018, and that's pressuring stocks across the home healthcare industry.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.